SynBiotic SE

Equities

SBX

DE000A3E5A59

Pharmaceuticals

End-of-day quote BOERSE DUESSELDORF Other stock markets 23:00:00 20/06/2024 BST			5-day change	1st Jan Change
7.44 ^EUR	-2.11%		-3.88%	+148.83%

05-14	WDH/Survey: Seven percent of adults have bought cannabis seeds	DP
05-09	Medical Cannabis Group SynBiotic Buys Local Peer Weeco Pharma	MT

SynBiotic SE acquired WEECO Pharma GmbH.

May 07, 2024

SynBiotic SE (DUSE:SBX) acquired WEECO Pharma GmbH on May 8, 2024.

SynBiotic SE (DUSE:SBX) completed the acquisition of WEECO Pharma GmbH on May 8, 2024.

Latest news about SynBiotic SE

WDH/Survey: Seven percent of adults have bought cannabis seeds	05-14	DP
Medical Cannabis Group SynBiotic Buys Local Peer Weeco Pharma	05-09	MT
SynBiotic SE acquired WEECO Pharma GmbH.	05-07	CI
SynBiotic Boosts CBD Business with Ilesol Pharmaceuticals Takeover	04-23	MT
SynBiotic SE acquired Ilesol Pharmaceuticals d.o.o. za proizvodnju i usluge.	04-22	CI
Cannabis law signed - release on April 1	03-27	DP
Controversial cannabis law has been signed	03-27	DP
TOTAL Federal Council paves the way for growth package and cannabis	03-22	DP
Federal Council clears the way for cannabis legalization	03-22	DP
Synbiotic continues to rise after cannabis legalization	03-22	DP
Circles/Cannabis dispute: Hesse wants to abstain in the Bundesrat	03-22	DP
Cannabis dispute: Baden-Württemberg in favor of mediation committee	03-22	DP
Synbiotic corrects after cannabis rally - legalization open	03-22	DP
Daniel Günther: Cannabis law to be postponed until October	03-22	DP
Cannabis dispute: Baden-Württemberg calls for mediation committee	03-22	DP
Cannabis law and clinic atlas in the Bundesrat	03-22	DP
Dreyer does not expect cannabis law to fail	03-19	DP
Drugs commissioner lobbies states for cannabis law	03-15	DP
Union interior ministers want to consider legal action against cannabis legalization	03-12	DP
Synbiotic share price fireworks continue - cannabis approval imminent	02-23	DP
Juvenile court judge Müller warns against scaremongering on cannabis	02-13	DP
SHARES IN FOCUS 2: Synbiotic and Cantourage rally - risk of correction feared	02-05	DP
SHARES FOCUS: Cannabis legalization drives Synbiotic and Cantourage upwards	02-05	DP
Drugs commissioner urges implementation of cannabis release	12-11	DP
SynBiotic SE Reports Earnings Results for the Full Year Ended December 31, 2022	21/08/23	CI

Chart SynBiotic SE

Duration

Period

More charts

Company Profile

SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Recreational Pharmaceuticals

	1st Jan change	Capi.
SYNBIOTIC SE	+148.83%	37.19M
CURALEAF HOLDINGS, INC.	+1.81%	3.04B
TRULIEVE CANNABIS CORP.	+97.81%	1.85B
GOODNESS GROWTH HOLDINGS, INC.	+96.83%	66.48M
SIMPLY BETTER BRANDS CORP.	+277.27%	52.09M

Recreational Pharmaceuticals